970
Views
11
CrossRef citations to date
0
Altmetric
Drug Evaluation

Belimumab in the management of systemic lupus erythematosus – an update

&
Pages 901-908 | Received 11 Feb 2017, Accepted 26 Apr 2017, Published online: 16 May 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zdenka Hruskova & Vladimir Tesar. (2018) Lessons learned from the failure of several recent trials with biologic treatment in systemic lupus erythematosus. Expert Opinion on Biological Therapy 18:9, pages 989-996.
Read now

Articles from other publishers (10)

Chi Chiu Mok, Y. K. Onno Teng, Ramesh Saxena & Yoshiya Tanaka. (2023) Treatment of lupus nephritis: consensus, evidence and perspectives. Nature Reviews Rheumatology 19:4, pages 227-238.
Crossref
Carlos Rodríguez Escalera, Ángela María Zurita Guisado, Francisco Javier Mateo, Noemí Bahamontes-Rosa & María Jesús García Villanueva. (2022) Use of belimumab in real-world in Spain: a scoping review about characteristics of SLE patients. Clinical Rheumatology 41:11, pages 3373-3382.
Crossref
Champa Nataraja, Wendy Zhu, Wendy Dankers & Sarah A. Jones. 2021. Pathogenesis of Systemic Lupus Erythematosus. Pathogenesis of Systemic Lupus Erythematosus 161 178 .
Shima Afzali, Saeedeh Salehi, Abbas Shahi & Aliakbar Amirzargar. (2020) B cell modulation strategies in the improvement of transplantation outcomes. Molecular Immunology 125, pages 140-150.
Crossref
B. G. Isayeva, M. M. Saparbayeva, S. M. Isayeva, M. M. Kulshymanova, Sh. M. Kaiyrgali, M. P. Bizhanova, K. Zh. Nurgaliyev, L. Kosherbayeva, B. A. Kulymbetova, K. K. Rysbekova, S. K. Solovyev & E. A. Aseeva. (2020) The current status of the problem with systemic lupus erythematosus in Kazakhstan. Modern Rheumatology Journal 14:1, pages 32-39.
Crossref
S. K. SolovyovA. A. MesnyankinaE. A. Aseeva. (2019) Prospects for anti-BLyS treatment of systemic lupus erythematosus. Medical Council:9, pages 92-95.
Crossref
A. A. Mesnyankina, S. K. Solovyev, E. A. Aseeva, A. P. Aleksankin, E. N. Aleksandrova & E. L. Nasonov. (2019) Effect of biological agents on B-lymphocyte subpopulations in patients with systemic lupus erythematosus. Modern Rheumatology Journal 13:1, pages 35-43.
Crossref
Yasuo Nagafuchi, Hirofumi Shoda & Keishi Fujio. (2019) Immune Profiling and Precision Medicine in Systemic Lupus Erythematosus. Cells 8:2, pages 140.
Crossref
Yumi Tsuchida & Keishi Fujio. 2019. Mosaic of Autoimmunity. Mosaic of Autoimmunity 127 141 .
A. A. Mesnyankina, S. K. Solovyev, E. A. Aseeva & E. L. Nasonov. (2018) THE EFFICIENCY OF BIOLOGICAL THERAPY AND THE FEATURES OF HUMORAL IMMUNITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Rheumatology Science and Practice 56:3, pages 302-309.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.